Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: application to rhabdomyolysis
Open Access
- 21 September 2011
- journal article
- Published by Oxford University Press (OUP) in Journal of the American Medical Informatics Association
- Vol. 18 (Supplement), i73-i80
- https://doi.org/10.1136/amiajnl-2011-000417
Abstract
Background Adverse drug events (ADE) cause considerable harm to patients, and consequently their detection is critical for patient safety. The US FoodKeywords
This publication has 39 references indexed in Scilit:
- Severe Rhabdomyolysis as a Consequence of the Interaction of Fusidic Acid and AtorvastatinAmerican Journal of Kidney Diseases, 2010
- Statistical Mining of Potential Drug Interaction Adverse Effects in FDA's Spontaneous Reporting System.2010
- Telbivudine: rhabdomyolysis and neuropathy.2010
- In silico toxicology for the pharmaceutical sciences☆Toxicology and Applied Pharmacology, 2009
- Mechanisms of Zidovudine-Induced Mitochondrial Toxicity and MyopathyPharmacology, 2008
- Novel 2D Fingerprints for Ligand-Based Virtual ScreeningJournal of Chemical Information and Modeling, 2006
- Automated Encoding of Clinical Documents Based on Natural Language ProcessingJournal of the American Medical Informatics Association, 2004
- Do Structurally Similar Molecules Have Similar Biological Activity?Journal of Medicinal Chemistry, 2002
- Anticholinergic syndrome with severe rhabdomyolysis--an unusual feature of amantadine toxicity.1997
- Pathogenesis and treatment of neuroleptic malignant syndromeGeneral Pharmacology: The Vascular System, 1990